Showing results (421-430 of 1,644) with videos related to
Sort By:
Pageof 165
Children (Basel, Switzerland)|December 23, 2023
Navigating Challenges and Advances in Pediatric Psoriasis and Atopic Dermatitis TreatmentKatie K Lovell, Lindsay C Strowd, Steven R FeldmanCutis|October 30, 2023
Concurrent Atopic Dermatitis and Psoriasis Successfully Treated With Dual Biologic TherapyMargaret A Kaszycki, Jessica N Pixley, Steven R FeldmanClinical and Experimental Dermatology|May 29, 2026
Eczema Action Plans: Do They Improve Objective Disease Outcomes?Priya Kadu, Chenan Huang, Matthew Zirwas, et al.Expert Review of Clinical Immunology|June 22, 2016
Current status and future prospects for biologic treatments of psoriasisAbigail Cline, Dane Hill, Robin Lewallen, et al.Expert Opinion on Drug Metabolism & Toxicology|September 11, 2023
JAK1 inhibitors for the treatment of atopic dermatitis: a focus on pharmacokinetic considerationsHannah Kopelman, Christina Kontzias, Christopher Alihosseni, et al.Journal of Drugs in Dermatology : JDD|October 6, 2023
Cidofovir in the Management of Non-Genital Warts: A ReviewMadison K Cook, Erin M Hagen, Steven R FeldmanJournal of the American Academy of Dermatology|July 26, 2002
Off-label prescribing in the treatment of dermatologic diseaseJoel H Sugarman, Alan B Fleischer, Steven R FeldmanJournal of Professional Nursing : Official Journal of the American Association of Colleges of Nursing|November 17, 2001
A case study in implementing CQI in a nursing education programE Yearwood, J Singleton, H R Feldman, et al.The Journal of Dermatological Treatment|October 28, 2022
Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasisRachel C Ruda, Katherine A Kelly, Steven R FeldmanSeminars in Cutaneous Medicine and Surgery|May 20, 2005
The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis careKevin R Stein, Daniel J Pearce, Steven R FeldmanPageof 165